Navigation
Markedsudsigter Stock Screener Udbyttekalender Begivenhedskalender Bedømmelse af aktier Markedsnyheder
Prøv gratis

Opiant Pharmaceuticals

NASDAQ OPNT
$20.65 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 25 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

106.11M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
68.59M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
0.51
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
5.14M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-

Upcoming events Opiant Pharmaceuticals

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Opiant Pharmaceuticals

Stock analysis Opiant Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-3.21 8.71
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
2.27 24.46
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-2.18 4.36
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
1.19 0.50
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-161.39 9.54

Price change Opiant Pharmaceuticals per year

6.79$ 28.61$
Min Max

Summary analysis Opiant Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Opiant Pharmaceuticals

Revenue and net income Opiant Pharmaceuticals

All parameters

Stock news Opiant Pharmaceuticals

All news
6 februar 2023 в 16:45

Indivior Says Waiting Period for Opiant Pharmaceuticals Acquisition Expired

6 februar 2023 в 16:45

Indivior Says Waiting Period for Opiant Pharmaceuticals Acquisition Expired

14 november 2022 в 14:00

Opiant Pharmaceuticals Shares Surge Premarket on Takeover by Indivior >OPNT

14 november 2022 в 14:00

Opiant Pharmaceuticals Shares Surge Premarket on Takeover by Indivior >OPNT

10 februar 2022 в 16:20

Opiant Pharmaceuticals Sees Positive Results from Nalmefene Study

10 februar 2022 в 16:20

Opiant Pharmaceuticals Sees Positive Results from Nalmefene Study

9 december 2021 в 16:00

Opiant Pharmaceuticals started at outperform with $42 stock price target at Oppenheimer

About company Opiant Pharmaceuticals

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.
Address:
233 Wilshirre Boulevard, Santa Monica, CA, United States, 90401
Company name: Opiant Pharmaceuticals
Issuer ticker: OPNT
ISIN: US6837501039
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2016-01-04
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.opiant.com

On which stock exchange are Opiant Pharmaceuticals (OPNT) stocks traded?

Opiant Pharmaceuticals (OPNT) stocks are traded on NASDAQ.

What is the ticker of Opiant Pharmaceuticals stocks (OPNT)?

The stock ticker of Opiant Pharmaceuticals’s stocks or in other words, the code is OPNT. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Opiant Pharmaceuticals (OPNT) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Opiant Pharmaceuticals (OPNT) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Opiant Pharmaceuticals (OPNT) stocks traded?

Opiant Pharmaceuticals (OPNT) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Opiant Pharmaceuticals (OPNT) stocks today?

The current price of Opiant Pharmaceuticals stocks on 18.05.2024 is 20.65 dollars. per share.

What is the dynamics of Opiant Pharmaceuticals (OPNT) stocks from the beginning of the year?

Opiant Pharmaceuticals (OPNT) quotes have increased by 0% from the beginning of the year up to 20.65 dollars. per 1 stocks.

How much did Opiant Pharmaceuticals (OPNT) stocks increase in мае 2024?

This month Opiant Pharmaceuticals (OPNT) quotes have increased by 0% to 20.65 dollars. per share.

How much are Opiant Pharmaceuticals (OPNT) stocks worth?

Today, on October, 18.05.2024 Opiant Pharmaceuticals’s (OPNT) stocks cost 20.65 dollars..

What is the market capitalization of Opiant Pharmaceuticals (OPNT)?

Capitalization is the market value of Opiant Pharmaceuticals (OPNT) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 18.05.2024, the market capitalization of Opiant Pharmaceuticals (OPNT) is estimated at about 106105358 dollars.